Tag - MTEM

Markets

Stifel starts Molecular Templates at buy; PT $19

Stifel initiated coverage of Molecular Templates (NASDAQ:MTEM) with a “buy” rating and $19 price target. The stock closed at $13.29 on March 24. “We believe the engineered toxin body technology from which Molecular’s...

March 25, 2020

Developments

Molecular Templates IND for HER2-targeted therapy accepted by FDA 

Molecular Templates (NASDAQ:MTEM) IND application for MT-5111, an engineered toxin body targeting HER2, has been accepted by the FDA. MT-5111’s single chain variable fragment and Shiga-like toxin-A subunit respectively...

April 22, 2019

Tag - MTEM

Stifel starts Molecular Templates at buy; PT $19

Molecular Templates IND for HER2-targeted therapy accepted by FDA

General

More

Tag - MTEM

Stifel starts Molecular Templates at buy; PT $19

Molecular Templates IND for HER2-targeted therapy accepted by FDA&nbsp;

General

More

Molecular Templates IND for HER2-targeted therapy accepted by FDA